Skip to main content

Cambridge UK: 18 August 2026

Penningtons Manches Cooper has renewed its partnership with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs of the One Nucleus Members, the Partner and One Nucleus in delivering on its core remit of supporting innovation.

Rachel Bradley, Partner at Penningtons Manches Cooper commented:

"Our long-standing relationship with One Nucleus reflects our shared commitment to supporting the success of innovative life sciences businesses. We are pleased to renew our partnership and continue engaging with a community that is driving scientific and technological advances with real-world impact.

One Nucleus provides an invaluable platform for connecting industry leaders, investors, advisers and entrepreneurs, and we are proud to contribute our sector knowledge and legal expertise to that network. We look forward to building on the strong relationships developed through the partnership and supporting members as they navigate their growth journeys."

Tony Jones, CEO of One Nucleus expands further ‘We are delighted to renew our long-standing collaboration with Penningtons Manches Cooper through the One Nucleus Partner Programme. A key part of our role is to signpost members to trusted advisors who can support them at critical stages of their growth, and this partnership helps create an environment where those conversations can take place, connecting our community to the firm’s specialist expertise across intellectual property, corporate, and commercial law. In turn, it provides Penningtons Manches Cooper with ongoing opportunities to develop and deepen relationships with innovative life science organisations, while maintaining insight into their evolving needs and challenges,”

About Penningtons Manches Cooper
Penningtons Manches Cooper is a leading UK and international law firm with a strong reputation in the life sciences, healthcare and technology sectors. The firm advises clients ranging from start-ups, spin-outs and investors to established multinational businesses on a full range of legal matters, including intellectual property, corporate transactions, commercial agreements, regulatory issues, employment and dispute resolution. Through its sector-focused approach and deep industry knowledge, the firm helps innovative organisations achieve their commercial objectives and navigate complex legal challenges.

About One Nucleus
One Nucleus's vision is to supercharge bio-innovation.

Its mission is to inspire, inform, and implement by connecting bio-innovation leaders and their companies with knowledge, investment, and deal-flow opportunities in a capital-efficient way, supporting organisations from start-up through to exit.

As a not-for-profit life science membership organisation, One Nucleus brings together stakeholders from across the sector to help them achieve their aspirations on the global stage.

Media Contact Information :

Tony Jones, CEO
Email: [email protected]
Tel: +44 (0)1223 896463
Web:  www.onenucleus.com

Rachel Bradley, Partner at Penningtons Manches Cooper
[email protected]
+44 (0)1223 465427
https://www.penningtonslaw.com/